Member Info for jdt1990

Agreed Wimbo - Now he's cemented a third salary for himself for the foreseeable, hopefully he can focus his attention on delivering something here!

There’s no doubt there’s plenty in our favour with regards to the EP. We’re also operating in a pro mining country who stand to make good money from a tax perspective from foreign gold miners. With POG where it is I would very much hope this is an admin based delay off the back of Covid.
However, from a PR perspective, having “a few weeks” as the timeline in each RNS will inevitably get people twitchy as time goes on. Always find on AIM it’s best to underpromise and over deliver not vice ever said!

The NYCT lot wish they had what we had. Roll on the deramp brigade. Only one solution to the problem!

Avct is better that’s all you need to know!

It’s not brilliantly written, I mean it is dailymail, hence I think some people think it is talking about one test. However, why would you describe a pregnancy test as “about the size of a teacup that plugs into the wall”. I agree that he’s talking about 2 different things, the pregnancy style one has to be AVCTs

Saintsmith - just so happens that every time AS opens the fridge door there is another Narnia like world for AVCT to explore, make a meaningful impact on the medical world and generate revenues - funded by large pharmas nonethelss. Little different from your beloved NCYT. Jealousy is a really poor quality - jog on

It's also a god way to promote staff retention when you're not making significant revenues/profits to pay bonuses out of. Pleases both sides - the business doesn't have to use precious capital to incentivise the staff and the staff who believe in the future potential of the business get some "golden tickets"

can you enlighten me on how you think you close a short position by selling? you have to buy back to close a short.....that would drive the price up

With regards to first mover advantage, the other thing to consider is if we can tie some buyers into regular contracts (say airports or large workplaces for 6m-1Y with a weekly or monthly delivery) then even if there are new players coming to market, it wont reduce AVCT's order sizes and revenues

To me it seems AS has made it very clear (especially from the placing RNS) AVCT is 2 very distinct business lines Diagnostic and Theraputics. Quite a clever move should someone really want the Affimer tech after COViD has proved just how revolutionary it is. I think AS has the passion for the oncology side and possibly if there was a takeover, we could see that being solely for the diagnostics business short term.

Wiggly, you my man (woman) are on fire today!

Great find Wiggly on the testing commons link. As that covers worldwide, have to agree with you, the writing is on the wall.

he also said the new tech they are testing includes homegrown tech which adds to the chances this is us

Anyone on this bb know or is a GP in Southampton or employee at Southampton Uni? If you get a test to trial, let us know if it is a pregnancy style LFT....then there is the end yo any speculation....

Southampton City Council Director of Public Health Debbie Chase said:

We will initially invite Southampton’s 800-strong GP practice workforce and their households to take part, followed by some other essential key workers and some University of Southampton staff and students as we evaluate the logistics needed for regular testing of large population groups.

@tig - I do wonder, given the fact these are our 100% owned sites and we aren't bound by the 6 week cycle of drill results from NCM like we are for Hav, we could realistically see some initial sample results quite soon if they are worth shouting about. Plenty to come on this front I think and it looks like the infrastructure has been in place for this for a while so GH clearly means business!

Well it’s a good job this is heading towards being a vertically integrated business where we aren’t reliant solely on the high price of vanadium as a lower price benefits Bushveld energy to some extent. Making some solid profits still at current prices, post COViD there will be plenty of infrastructure projects. No concerns here from me...

JG88 - I would firstly suggest you determine whether you are a trader or this is an investment. They are very different things. If you are trying to trade it then actually this kind of movement makes it an attractive opportunity to buy some more knowing the regularity of newsflow here.
If this is an investment then 2 things to consider:
1. A 10% loss is only a loss when you sell. Hit the LSE chart button and set the time series to 3Y, that will give you a good indication that nothing goes up in a straight line short term, but boy this is not far off doing medium to long term.
2. The fundamentals are amazing here, the BOD so far have behaved impeccably with regards to generating and protecting shareholder value, the POG is going one way. Just be patient and believe in your research. Mining isn't a quick turnaround, this isnt an episode of aussie gold hunters where a fella with a detector finds some nuggets and sells them. This is an exploration business, exploration, license appplication, heritage surveys.....so many hoops to jump through ebfore you can even mine the stuff, and its worth a lot less in the ground until you can get it out.
3. If this the largest shareholding in your portfolio and you are worried about a 10% paper loss on it that you can't wait to see head back into profit over the next months and years, you've probably overexposed yourself sorry to say. You may get lucky a few times with a quick multibagger but you should only do that with money you can afford to lose.

except the board also get a salary out of this company - PI's dont

Absolutely right MilkMonsta. There was pretty much no value assigned to what Avacta was doing in the cancer space a few months ago. The COViD work has clearly shows what AVCT are capable of as a business and how quickly they can move with the right backing. Hence the big names involved in the placing and existing partners adding more substance to their agreements.
There’s no doubt in my mind this company is going places and the COViD plays have opened the doors to start to realise (very quickly) the true value of what this company is doing in the oncology space

Stevehoops - that is a ballsy average down strategy on a company that has produced nothing commercially viable other than a lifelong pension flow for Conroy from shareholder pockets.
I hope for your sake he does deliver!